HOMEVULNERABILITIESCVE-2024-3700
CRITICAL

CVE-2024-3700

CWE-259Published: June 10, 2024· Updated: Jun 17, 2026

9.8
CVSS v3.1

Official Description

Use of hard-coded password to the patients' database allows an attacker to retrieve sensitive data stored in the database. The password is the same among all Simple Care software installations.

This issue affects Estomed Sp. z o.o. Simple Care software in all versions. The software is no longer supported.

NVD Source

Technical Analysis

CVE-2024-3700 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 9.8.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

estomed1 product(s)
simple care
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (4)

Quick Facts

CVE IDCVE-2024-3700
CVSS Score9.8 / 10
SeverityCRITICAL
WeaknessCWE-259
CISA KEVNo
Affected1 vendor(s)
PublishedJun 10, 2024

Related CVEs (CWE-259)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2024-3700 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.